Company Immunoprecise Antibodies Ltd Other OTC
Equities
CA87588T1030
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Production Project
90.4
%
| 14 | 89.6 % | 14 | 90.4 % | +1.56% |
Antibody Production Product
8.5
%
| 1 | 8.5 % | 1 | 8.5 % | -0.20% |
Cryostorage
1.2
%
| 0 | 1.8 % | 0 | 1.2 % | -36.11% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
45.7
%
| 8 | 48.7 % | 7 | 45.7 % | -5.42% |
United States
45.3
%
| 5 | 35.2 % | 7 | 45.3 % | +29.67% |
Australia
3.0
%
| 1 | 8.0 % | 0 | 3.0 % | -61.39% |
Canada
3.0
%
| 0 | 3.0 % | 0 | 3.0 % | +1.96% |
Other
2.9
%
| 1 | 5.2 % | 0 | 2.9 % | -43.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 20/02/18 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 28/09/23 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Frederick Chabot
IRC | Investor Relations Contact | - | - |
Barry Duplantis
PRN | Corporate Officer/Principal | - | - |
Kari Graber
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 04/09/23 |
Jennifer Bath
CEO | Chief Executive Officer | - | 20/02/18 |
Dirk Witters
BRD | Director/Board Member | - | 04/09/23 |
Barry Springer
BRD | Director/Board Member | - | 04/09/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,315,260 | 22,738,411 ( 86.41 %) | 0 | 86.41 % |
Company contact information
ImmunoPrecise Antibodies Ltd.
4464 Markham Street Suite 3204
V8Z 7X8, Victoria
+250-483-0308
http://www.immunoprecise.com![address Immunoprecise Antibodies Ltd](https://cdn.zonebourse.com/static/address/73628.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+2.97% | 94.74B | |
-3.68% | 37.28B | |
-11.61% | 32.68B | |
+74.21% | 27.72B | |
-13.40% | 16.19B | |
-2.29% | 13.88B | |
-12.21% | 11.58B | |
+188.83% | 10.92B | |
-53.94% | 9.54B |